Researchers used AI models to design antibodies that neutralize over 1,300 SARS-CoV-2 strains, including Delta and Omicron.

During a live event, Krish Patel, MD, surveyed participants on using bispecific T-cell engagers vs loncastuximab in a patient with relapsed diffuse large B-cell lymphoma who had prior CAR T-cell ...

Cheyney, PA, May, 5 2025 - Navrogen, Inc., a biopharmaceutical company specialized in developing antibody-based therapies for ...

A Wisconsin man has been bitten by snakes hundreds of times, and scientists are studying his blood to treat snakebite.

Scientists have developed the most broadly protective antivenom yet, using antibodies from a donor who built immunity through ...

Scientists have found that receiving a COVID-19 booster shot in the same arm as the initial dose triggers a faster and more effective immune response, thanks to primed macrophages in nearby lymph ...

A man spent 18 years injecting himself with venom, almost dying more than once – and now his blood is behind a new snakebite ...

Lipids are the fatty molecules that make up cellular membranes, creating a protective barrier that regulates what enters and ...

Participants in the CLL11 trial and a smaller group of patients followed after study completion showed improved overall ...

Same-arm booster shots trigger a stronger early immune response than shots given in the opposite arm, leading to higher ...

This study highlights the promising potential of LC–MS as a powerful tool for mAb quality control within the context of upstream processing.

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...